Geron Corporation
GERNBiotechnology
$0.89−5.47%As of Oct 30vs prior close
- Market cap
- $574.6M
- P/E (TTM)
- –
- From 52W high
- −54.13%
- EPS (LTM)
- -$0.11
- Revenue (YE23)
- $237K
Nomior Score
50
Steady ProfileSpeculativeBottom 50% of the scored universe
Growth58
Quality55
Value57
Momentum42
Resilience42
Growth
−37.21%revenue a year over 7 fiscal years
YE16 $6.2MYE23 $237K
Connections
Revenue to profitQ2 YE26
The operating loss was 22% of revenue, narrower by 4 pts on a year.
Who owns it
2funds